Amanote Research
Register
Sign In
P2.01-107 Analysis of Mutation Detection by ctDNA on the Basis of Metastatic Sites in Lung Adenocarcinoma Patients
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1162
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
R. Guo
H. Xu
J. Zhang
X. Ai
L. Liu
J. Zhao
X. Dong
L. Miao
R. Chen
X. Xia
Publisher
Elsevier BV
Related search
P2.01-100 Different Genetic Mutations Enriched in Circulating Tumor DNA Predict Different Metastatic Sites in Lung Adenocarcinoma Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Rare Metastatic Sites of a Lung Adenocarcinoma
Cureus
P2.01-66 Comparison of EGFR Mutation Status in Tissue and Plasma Cell-Free DNA Detected by ARMS in Advanced Lung Adenocarcinoma Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.01-05 Adenocarcinoma of the Lung: The Woman’s Cancer?
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.01-101 Dynamic Monitoring of Gene Alterations With ctDNA by NGS for EGFR Mutated Lung Adenocarcinoma Treated With Gefitinib in BENEFIT Study (CTONG 1405)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
The Profile of Lung Adenocarcinoma Patients With Positive EGFR Mutation
Green Medical Journal
Prospective Analysis of Patients Treated With Chemotherapy in Metastatic Adenocarcinoma of Lung—Single Centre Experience
Journal of Cancer Therapy
P2.01-78 Validation of InVisionFirst ctDNA NGS Profiling via ddPCR Testing in Patients With Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.01-08 Conversion Surgery for Locally Advanced Lung Adenocarcinoma Harboring Driver Gene Mutation After TKI Followed by Cytotoxic Agent
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
